352348-41-5

Basic information

• Product Name: 4-{[3-(4-cyano-phenyl)-3-aza-spiro[5.5]undecane-9-carbonyl]-amino}-butyric acid ethyl ester
• Synonyms: 4-{[3-(4-cyano-phenyl)-3-aza-spiro[5.5]undecane-9-carbonyl]-amino}-butyric acid ethyl ester
• CAS NO: 352348-41-5
• Molecular Weight: 411.544
• Mol File: 352348-41-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-{[3-(4-cyano-phenyl)-3-aza-spiro[5.5]undecane-9-carbonyl]-amino}-butyric acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-{[3-(4-cyano-phenyl)-3-aza-spiro[5.5]undecane-9-carbonyl]-amino}-butyric acid ethyl ester(352348-41-5)
• EPA Substance Registry System: 4-{[3-(4-cyano-phenyl)-3-aza-spiro[5.5]undecane-9-carbonyl]-amino}-butyric acid ethyl ester(352348-41-5)

Safety Data

• Hazardous Substances Data: 352348-41-5(Hazardous Substances Data)

Upstream product

• 5959-36-4 ethyl 4-aminobutyrate 
• 352347-92-3 3-(4-cyano-phenyl)-3-aza-spiro[5.5]undecane-9-carboxylic acid ethyl ester 
• 623-00-7 4-bromobenzenecarbonitrile 

Downstream Products

• 352348-44-8 4-{[3-(4-carbamimidoyl-phenyl)-3-aza-spiro[5.5]undecane-9-carbonyl]-amino}-butyric acid ethyl ester 

Relevant articles and documents

Spirocyclic nonpeptide glycoprotein IIb-IIIa antagonists. Part 2: Design of potent antagonists containing the 3-azaspiro[5.5]undec-9-yl template

The synthesis and biological activity of novel glycoprotein IIb-IIIa anatagonists containing 3-azaspiro[5.5]undec-9-yl nucleus are described. The potent activity of these compounds as platelet aggregation inhibitors demonstrates the utility of the monoaza